1. Home
  2. BLBD vs IVA Comparison

BLBD vs IVA Comparison

Compare BLBD & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blue Bird Corporation

BLBD

Blue Bird Corporation

HOLD

Current Price

$53.38

Market Cap

1.7B

ML Signal

HOLD

Logo Inventiva S.A. American Depository Shares

IVA

Inventiva S.A. American Depository Shares

HOLD

Current Price

$5.99

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLBD
IVA
Founded
1927
2011
Country
United States
France
Employees
N/A
84
Industry
Construction/Ag Equipment/Trucks
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.4B
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
BLBD
IVA
Price
$53.38
$5.99
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
10
Target Price
$67.20
$16.20
AVG Volume (30 Days)
392.7K
315.6K
Earning Date
05-11-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
22.78
N/A
EPS
0.94
N/A
Revenue
$1,480,099,000.00
N/A
Revenue This Year
$6.07
N/A
Revenue Next Year
$6.37
N/A
P/E Ratio
$56.91
N/A
Revenue Growth
9.87
N/A
52 Week Low
$30.15
$2.70
52 Week High
$62.90
$7.98

Technical Indicators

Market Signals
Indicator
BLBD
IVA
Relative Strength Index (RSI) 40.99 43.83
Support Level $49.55 $5.79
Resistance Level $58.25 $6.48
Average True Range (ATR) 2.03 0.30
MACD -0.95 -0.05
Stochastic Oscillator 10.05 9.70

Price Performance

Historical Comparison
BLBD
IVA

About BLBD Blue Bird Corporation

Blue Bird Corp is an American bus manufacturing company. It is an independent designer and manufacturer of school buses. The company operates in two segments; the Bus segment which involves the design, engineering, manufacture, and sales of school buses and extended warranties; and the Parts segment which includes the sales of replacement bus parts. Geographically, the company generates a majority of its revenue from its customers in the United States and the rest from Canada and Rest of the world.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

Share on Social Networks: